This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1976 Jun;60(6):807-11.

The nitrosoureas--thoughts for the future

S K Carter, T H Wasserman

PMID: 954014

The nitrosoureas--thoughts for the future

S K Carter et al. Cancer Treat Rep. 1976 Jun.

. 1976 Jun;60(6):807-11.

Authors

S K Carter, T H Wasserman

PMID: 954014

No abstract available

PubMed Disclaimer

Similar articles

Therapy for gastrointestinal cancer with the nitrosoureas alone and in drug combination.
Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Moertel CG, et al. Cancer Treat Rep. 1976 Jun;60(6):729-32. Cancer Treat Rep. 1976. PMID: 954012 No abstract available.
Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
Douglass HO Jr, Lavin PT, Moertel CG. Douglass HO Jr, et al. Cancer Treat Rep. 1976 Jun;60(6):769-80. Cancer Treat Rep. 1976. PMID: 782699 Clinical Trial.
Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
Baker LH, Vaitkevicius VK, Gehan E. Baker LH, et al. Cancer Treat Rep. 1976 Jun;60(6):733-7. Cancer Treat Rep. 1976. PMID: 954013 Clinical Trial.
Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
Trux F. Trux F. Hepatogastroenterology. 1982 Jun;29(3):130-3. Hepatogastroenterology. 1982. PMID: 7049880 Review. No abstract available.
Contributions of nitrosoureas to cancer treatment.
Mitchell EP, Schein PS. Mitchell EP, et al. Cancer Treat Rep. 1986 Jan;70(1):31-41. Cancer Treat Rep. 1986. PMID: 3002621 Review. No abstract available.

See all similar articles

Cited by

Treatment of metastatic brain tumors with the combination of 1-methyl-1-nitrosourea (MNU) and cyclophosphamide.
Kolarić K, Roth A. Kolarić K, et al. J Cancer Res Clin Oncol. 1980;97(2):193-8. doi: 10.1007/BF00409905. J Cancer Res Clin Oncol. 1980. PMID: 7462297 Free PMC article.
Renal effects of S10036 in man.
Deray G, Khayat D, Jacquiaud C, Bizzari JP, Bourbouze R, Musset L, Jaudon MC, Baumelou B, Jacquillat C, Jacobs C. Deray G, et al. Cancer Chemother Pharmacol. 1990;26(6):467-8. doi: 10.1007/BF02994102. Cancer Chemother Pharmacol. 1990. PMID: 2225319 Clinical Trial.
Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.
Wedge SR, Porteus JK, May BL, Newlands ES. Wedge SR, et al. Br J Cancer. 1996 Feb;73(4):482-90. doi: 10.1038/bjc.1996.85. Br J Cancer. 1996. PMID: 8595163 Free PMC article.
DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas.
Erickson LC, Bradley MO, Ducore JM, Ewig RA, Kohn KW. Erickson LC, et al. Proc Natl Acad Sci U S A. 1980 Jan;77(1):467-71. doi: 10.1073/pnas.77.1.467. Proc Natl Acad Sci U S A. 1980. PMID: 6928639 Free PMC article.
Phase-I-II study of high-dose melphalan and autologous marrow transplantation in adult patients with poor-risk non-Hodgkin's lymphomas.
Mascret B, Maraninchi D, Gastaut JA, Baume D, Sebahoun G, Lejeune C, Novakovitch G, Sainty D, Horchowski N, Tubiana N, et al. Mascret B, et al. Cancer Chemother Pharmacol. 1985;14(3):216-21. doi: 10.1007/BF00258119. Cancer Chemother Pharmacol. 1985. PMID: 3888429

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions